Literature DB >> 8752845

Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes.

J B Travers1, K A Harrison, C A Johnson, K L Clay, J G Morelli.   

Abstract

Platelet-activating factor (PAF) is a potent inflammatory mediator that is thought to play a role in cutaneous inflammation. These studies used mass spectrometry to examine the molecular species of PAF precursor glycerophosphocholine lipids (GPC) as well as the biosynthesis of PAF and other sn-2 acetyl-GPC in a human keratinocyte-derived cell line (HaCaT keratinocytes). Approximately 28% of HaCaT keratinocyte GPC consisted of 1-alkyl species, and the relative amounts of the sn-1 alkyl constituents of the PAF precursor 1-alkyl-2-acyl-GPC were as follows: hexadecyl > octadecenyl > octadecyl. Ionophore (A23187)-stimulated HaCaT keratinocytes synthesized both PAF (1-hexadecyl, 1-octadecenyl, and 1-octadecyl species) and less potent 1-acyl analogs (1-palmitoyl, 1-oleoyl, and 1-stearoyl species). PAF production was rapid and maximal by 10 min. The major species of sn-2acetyl-GPC at 2.5 min were 1-hexadecyl-2-acetyl-GPC (2.2 ng/10(6) cells) and 1-palmitoyl-2-acetyl-GPC (2.4 ng/10(6) cells). HaCaT keratinocytes also synthesized PAF and 1-acyl PAF analogs when stimulated with the peptide growth factor endothelin-1 and the nonhydrolyzable PAF receptor agonist carbamyl-PAF. Both 1-hexadecyl-2- acetyl-GPC and 1-palmitoyl-2-acetyl-GPC stimulated intracellular calcium mobilization in HaCaT cells, indicating that these sn-2 acetyl-GPC act in autocrine fashion. These studies revealed that the human keratinocyte-derived cell line HaCaT can synthesize significant amounts of PAF and 1-acyl analogs in vitro from both nonspecific (A23187) and specific (endothelin-1, carbamyl-PAF) stimulation, suggesting a role for this inflammatory lipid mediator in keratinocyte pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752845     DOI: 10.1111/1523-1747.ep12298295

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Activation of the epidermal platelet-activating factor receptor results in ICAM-1 expression.

Authors:  Y Pei; L C Dy; S Natarajan; J B Travers
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

2.  Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.

Authors:  Yongxue Yao; Kathleen A Harrison; Mohammed Al-Hassani; Robert C Murphy; Samin Rezania; Raymond L Konger; Jeffrey B Travers
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.

Authors:  Tej Pratap Singh; Barbara Huettner; Harald Koefeler; Gerlinde Mayer; Isabella Bambach; Katrin Wallbrecht; Michael P Schön; Peter Wolf
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Enhanced Platelet-Activating Factor Synthesis Facilitates Acute and Delayed Effects of Ethanol-Intoxicated Thermal Burn Injury.

Authors:  Kathleen A Harrison; Eric Romer; Jonathan Weyerbacher; Jesus A Ocana; Ravi P Sahu; Robert C Murphy; Lisa E Kelly; Townsend A Smith; Christine M Rapp; Christina Borchers; David R Cool; Gengxin Li; Richard Simman; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

5.  Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.

Authors:  Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Chikkamenahalli Lakshminarayana Lakshmikanth; Mosale Seetharam Sumanth; Kandahalli Venkataranganayaka Abhilasha; Chu-Huang Chen; Anita Thyagarajan; Ravi P Sahu; Jeffery Bryant Travers; Thomas M McIntyre; Kempaiah Kemparaju; Gopal Kedihithlu Marathe
Journal:  J Lipid Res       Date:  2018-08-23       Impact factor: 5.922

6.  Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.

Authors:  Qiwei Zhang; Nico Mousdicas; Qiaofang Yi; Mohammed Al-Hassani; Steven D Billings; Susan M Perkins; Katherine M Howard; Satoshi Ishii; Takao Shimizu; Jeffrey B Travers
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

7.  Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists.

Authors:  Jared B Travers; Damien Berry; Yongxue Yao; Qiaofang Yi; Raymond L Konger; Jeffrey B Travers
Journal:  Photochem Photobiol       Date:  2010-05-13       Impact factor: 3.421

8.  Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.

Authors:  Yongxue Yao; Jay E Wolverton; Qiwei Zhang; Gopal K Marathe; Mohammed Al-Hassani; Raymond L Konger; Jeffrey B Travers
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system.

Authors:  Qiwei Zhang; Yongxue Yao; Raymond L Konger; Anthony L Sinn; Shanbao Cai; Karen E Pollok; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

10.  Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production.

Authors:  Jay E Wolverton; Mohammed Al-Hassani; Yongxue Yao; Qiwei Zhang; Jeffrey B Travers
Journal:  Photochem Photobiol       Date:  2009-09-21       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.